Expert Opinion on Drug Delivery

About Expert Opinion on Drug Delivery

About Expert Opinion on Drug Delivery

Expert Opinion on Drug Delivery is a peer-reviewed scholarly journal published by Taylor and Francis Ltd. (United Kingdom). It focuses on Q1. Publication coverage spans 2004-2026.

Key indicators: ISSN 1742-5247, 1744-7593; H-index 152.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

• H-index (152): Exceptionally high — 152 articles have each been cited at least 152 times. This indicates deep, sustained influence in the field.

Publishing in Expert Opinion on Drug Delivery

An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.

• Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
• Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

• Audience match: Will the journal's readers cite and build on your findings?
• Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
• Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
• Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of Expert Opinion on Drug Delivery?
1742-5247, 1744-7593.

Who publishes Expert Opinion on Drug Delivery?
Taylor and Francis Ltd..

What are Expert Opinion on Drug Delivery's metrics?
H-index 152.

Is Expert Opinion on Drug Delivery peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.